GlassScriptPhysician profile
Haariss Bin Ilyas
NPI 1861886772
$314,267.16
in general payments reported to CMS, 2019-2025
32 companies · $154K in 2025
The $154K reported for 2025 was more than what 95% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $104 · 2021: $4,193 · 2022: $12K · 2023: $64K · 2024: $79K · 2025: $154K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $206K · Travel and Lodging: $46K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $16K · Entertainment: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $205,792.75 |
| Travel and Lodging | $46,443.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,250.00 |
| Food and Beverage | $15,814.19 |
| Entertainment | $124.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $194,759.55 | 2021-2025 | Cascadia Interbody System, N/A, Core |
| Vb Spine LLC | $31,839.49 | 2025 | Monterey Al, Stryker, Everest Spinal System |
| Heron Therapeutics, INC. | $27,912.49 | 2025 | Zynrelef, Aponvie |
| Kyocera Medical Technologies, INC. | $19,783.58 | 2025 | |
| Bioventus LLC | $12,023.95 | 2023-2025 | Bonescalpel & Sonicone (O.R.), None |
| Nexxt Spine LLC | $5,486.32 | 2024-2025 | Struxxure Mcs, Nexxt Spine Product Technology, Nexxt Spine Product Portfolio |
| Ossdsign USA Incorporated | $5,012.32 | 2025 | Ossdsign Catalyst |
| Globus Medical, INC. | $4,380.21 | 2023-2025 | Excelsius Gps, Xlif, Rise |
| Medacta USA, INC. | $3,706.21 | 2025 | Myspine, Mectalif |
| Nuvasive, INC. | $2,128.83 | 2021 | |
| Sc Medica | $1,519.00 | 2025 | |
| Cerapedics INC. | $1,342.34 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Life Spine, INC. | $1,330.13 | 2022-2023 | Prolift |
| Acuity Surgical Devices, LLC | $616.71 | 2024 | |
| Si-Bone, INC. | $525.65 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogennix, LLC | $234.91 | 2023 | Agilon |
| Intrinsic Therapeutics | $231.88 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic USA, INC. | $204.40 | 2019 | |
| Providence Medical Technology, INC. | $178.40 | 2023-2024 | |
| Osteocentric Technologies, INC. | $160.31 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Boston Scientific Corporation | $149.01 | 2024 | |
| Medtronic, INC. | $136.52 | 2023-2024 | Intellis Adaptivestim, Centerpiece Plate Fixation System |
| Augmedics INC. | $112.06 | 2023-2024 | Xvision |
| Captiva Spine INC | $110.89 | 2024 | Watchtower |
| Osteomed LLC | $103.68 | 2020 | |
| Kuros Biosciences USA, INC | $92.06 | 2023 | |
| Depuy Synthes Sales INC. | $40.74 | 2024 | Viper, Synfix Evolution |
| Orthofix Medical, INC. | $38.72 | 2022-2024 | Physio-Stim |
| Abbvie INC. | $38.24 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $28.44 | 2024 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $24.04 | 2022 | |
| Painteq LLC | $16.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haariss Ilyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.